Antimicrobial Resistance: A Slow-Moving Global Health Emergency
Antimicrobial resistance (AMR) — when bacteria, viruses, fungi, or parasites no longer respond to medicines designed to kill them — is one of the most pressing and persistent threats to global health.
It undermines modern medicine, complicates routine surgeries, jeopardizes cancer treatments, and increases the risk of prolonged illness and death.
Because resistant infections spread across borders, addressing AMR requires coordinated action across human health, animal health, agriculture, environment, and trade sectors.
Why AMR matters now
AMR reduces the effectiveness of widely used antibiotics and other antimicrobials, raising healthcare costs and threatening health security. Hospitals face rising numbers of hard-to-treat infections; neonatal, surgical, and immunocompromised patients are especially vulnerable. Agricultural use of antimicrobials contributes to resistance that can transfer to humans via food and the environment. Global travel and trade accelerate the spread of resistant strains.
Four pillars for slowing AMR
– Stewardship: Appropriate use of antimicrobials in humans and animals is essential. Clinicians should prescribe only when necessary, using the right drug, dose, and duration.
Farmers and veterinarians must adopt alternatives to routine antimicrobial use and implement preventive measures like vaccination and improved biosecurity.
– Infection prevention and control (IPC): Strong IPC in healthcare facilities—hand hygiene, sanitation, screening, isolation when needed, and robust waste management—reduces transmission of resistant pathogens. Community-level improvements in water, sanitation, and hygiene (WASH) also lower infection rates and antibiotic demand.
– Surveillance and diagnostics: Timely, accurate diagnostics prevent unnecessary antimicrobial use and inform targeted treatment. Strengthening laboratory networks and sharing surveillance data internationally helps detect emerging resistance and guide policy and clinical practice.
– Innovation and access: New antibiotics, rapid diagnostics, vaccines, and alternative therapies are needed, but development alone isn’t enough.
Equitable access models, sustainable financing, and market incentives are necessary to ensure innovations reach patients globally while stewardship protects their longevity.
Practical steps for different stakeholders
– Policymakers: Implement national action plans aligned with international frameworks; regulate and monitor antimicrobial use in healthcare and agriculture; invest in surveillance, WASH infrastructure, and IPC programs.
– Healthcare providers: Use clinical guidelines and point-of-care tests when available; educate patients on appropriate antibiotic use; participate in antimicrobial stewardship programs.
– Farmers and food producers: Adopt good husbandry practices, vaccination, and improved hygiene to reduce disease and the need for antimicrobials; phase out use of medically important antimicrobials for growth promotion.
– Citizens: Follow prescriptions exactly, never demand antibiotics for viral infections, complete courses when prescribed, practice good hygiene, and support policies that promote responsible antimicrobial use.
Why global coordination matters
No single country can eliminate AMR alone. Cross-border surveillance, data sharing, and coordinated policies reduce the risk of resistant strains spreading worldwide. Collaborative funding mechanisms can support research and ensure equitable distribution of new tools. Integrating AMR efforts within broader health system strengthening and pandemic preparedness enhances resilience.
Staying resilient
Reducing AMR protects the effectiveness of existing treatments and safeguards future medical advances. By combining stewardship, prevention, diagnostics, innovation, and international cooperation, progress is achievable. Individuals, clinicians, industry, and governments each have a role in slowing resistance and preserving antimicrobials as lifesaving tools for generations to come.